Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Adiponectin: Measure serum adiponectin levels in type2 diabetics on treatment and not on any treatment
Sponsors
kasturba medical college
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed as T2DM according to ADA guidelines Age 40-70 years on Oral Anti-diabetic Drugs for at least of 6 months duration. Group 1 : Control â??Type 2 diabetics Not on any medication Sample Size : 10 Group 2 : Type 2 diabetics already on Glimepiride + Metformin sample size: 30 Group 3 : Type2 diabetics already on DPP4 inhibitor(vildagliptin) + Metformin Sample Size : 30
Exclusion criteria
Exclusion criteria: Type 1 DM patients Patients on insulin therapies for type2 DM Patients with DKA/acute illness Patients on drugs known to alter adiponectin levels i.e. rosiglitazone, Temocapril, Candesartan, pravastatin, Efonidipine, nebivolol, niacin. Impaired renal (CKD) & liver function (CLD) Patients with serious cardiovascular disease & cerebrovascular conditions within 6 months before study enrolment Conditions that can alter HBA1C estimation â??known hematological, genetic variants Women who are pregnant or breastfeeding and diagnosed with Gestational diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum adiponectin levels in each groupTimepoint: at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| NATimepoint: NA | — |
Countries
India
Contacts
Public Contactkondam alekya
Kasturba medical college
Outcome results
None listed